Immunoassay is a test conducted to determine concentration of macromolecule in a solution using antibody or immunoglobulin. The macromolecule detected is known as analyte. Immunoassay is used to measure quantity of analytes in serum and urine for medical and research purposes. It is also used in qualitative, quantitative and radioactivity procedures to ensure accuracy of results obtained. High sensitivity and specificity of immunoassays are used to speed up the reactions.
Rising incidences of chronic & infectious disease and use of immunoassays in Oncology are factor propelling the growth of the world immunoassay market. In addition, technological advancements and sensitivity, cost effectiveness, & rapid analysis offered by immunoassays supplement the growth. However, low detection limit and implementation of excise duty by the U.S. Government are hindering the growth of this market. Expanding biotechnology & pharmaceutical industries and laboratory automation and emerging markets in Asia presents significant opportunities.
The world immunoassay market is segmented based on technology, product & services, application, end user, and geography. The technology segment is further classified into ELISA, fluorescence, colorimetric, chemiluminescence, rapid test, western blot, ELISPOT, and PCR. The products & services covered in the report are reagents & kits, analyzers, and software services. The applications discussed in the report are infectious disease, endocrinology, cardiology, oncology, and hematology. The end user segment is further classified into hospitals, clinical laboratories, blood banks, academic research centers, pharmaceutical companies, and biotechnology companies, and others. Worldly, the market is segmented into North America, Asia, Europe, and Latin America, Middle East and Africa (LAMEA).
The prominent manufacturers operating in the market are Roche Diagnostics Limited, Siemens Healthcare, Abbott Laboratories, Beckman Coulter, Ortho Clinical Diagnostics, BioMrieux, Bio-Rad Laboratories Inc., Alere Inc., Sysmex Corporation, and Becton, Dickinson & Company. Various strategies, such as expansions, collaborations, partnerships, mergers & acquisitions, expansions, joint ventures, and others have been adopted by prominent manufacturers to gain a strong foothold in the market.
KEY BENEFITS FOR STAKEHOLDERS:
KEY MARKET SEGMENTS:
Key Market Players:
SIMILAR MARKET STUDIES
Blood Market by Product [Whole Blood Collection (System and Reagents), Source Plasma Collections (System and Reagents) Blood Therapeutics (IVIG, Albumin, Hyperimmune, Factor VIII, Factor IX, and Others), Blood Typing Products (System and Reagents), Blood Screening (Systems and Reagents), Blood Processing Equipment & Associated Products (System and Reagents)] and End User (Blood & Blood Component Bank, Diagnostic Laboratories, Ambulatory Surgical Centers, Hospitals, and Others): Global Opportunity Analysis and Industry Forecast, 2017-2023
Blood is a major necessity for patients suffering from injuries and viral infections, which require blood transfusion. The patients are either given whole blood or blood components for quick recovery and healing, resulting into increased demand for blood banks.
July 2017 | $5370 | View Details >>
UPCOMING MARKET RESEARCH REPORTS
2017 © Copyright Big Market Research